We are live on ! Find out more
QNTM icon

Quantum Biopharma Class B Subordinate Voting Shares

17 hedge funds and large institutions have $515K invested in Quantum Biopharma Class B Subordinate Voting Shares in 2021 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

117% more call options, than puts

Call options by funds: $804K | Put options by funds: $370K

0% more funds holding

Funds holding: 17 → 17 (0)

0% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 6

2.25% less ownership

Funds ownership: 3.05% → 0.8% (-2.2%)

33% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 3

89% less capital inflows, than outflows

Capital inflows: $158K | Capital outflows: $1.49M

Holders
17
Holders Change
–
Holders Change %
0%
% of All Funds
0.3%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
2
Reduced
3
Closed
6
Calls
$804​K
Puts
$370​K
Net Calls
+$434​K
Net Calls Change
+$108​K

QNTM Hedge Fund Activity: Q3 2021 in Review

17 of the 5,733 institutional investors tracked by Wall St. Rank reported a position in Quantum Biopharma Class B Subordinate Voting Shares (QNTM) for Q3 2021, worth a combined $515K — down 73% from $1.91M a quarter earlier.

Fund positioning in QNTM was balanced in Q3 2021: 6 funds opened new positions, 6 closed out, 2 added to existing stakes and 3 trimmed.

The largest buyer was Vident Investment Advisory, opening a new position worth an estimated $69.3K. The largest seller was IQ EQ Fund Management, exiting entirely with an estimated $1.01M sold.

  • 17 institutional investors held Quantum Biopharma Class B Subordinate Voting Shares (QNTM) as of Q3 2021, unchanged from Q2 2021.
  • Funds reported $515K of Quantum Biopharma Class B Subordinate Voting Shares stock for Q3 2021, down 73% quarter-over-quarter.
  • 6 funds opened new Quantum Biopharma Class B Subordinate Voting Shares positions in Q3 2021 and 6 closed out, a net change of 0 holders.
  • The largest Quantum Biopharma Class B Subordinate Voting Shares buyer in Q3 2021 was Vident Investment Advisory, an estimated $69.3K added.
  • The largest Quantum Biopharma Class B Subordinate Voting Shares seller in Q3 2021 was IQ EQ Fund Management, an estimated $1.01M sold.

Based on aggregated 13F filings for Q3 2021.